JNJ4796

JNJ4796 is a small molecule, orally active fusion inhibitor that neutralizes influenza A group 1 viruses by mimicking broadly neutralizing antibodies and blocking hemagglutinin-mediated fusion. It is a valuable research tool for studying viral entry mechanisms and has demonstrated antiviral activity in both in vitro assays and in vivo animal models of influenza infection.